XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Loss for the period $ (1,021,653) $ (1,847,794)
Adjustments to reconcile loss for the period to net cash used in operating activities:    
Depreciation 13,518 16,138
Stock-based compensation 178,587 561,482
Change in the fair value of Warrants with down-round protection (77,947)
Linkage difference on principal of loans from stockholders 523 (911)
Changes in assets and liabilities:    
(Increase) in accounts receivable (9,981) (27,585)
Decrease in inventory 19,149 10,442
(Increase) decrease in other current assets (16,600) 5,128
Operating lease right-of-use assets 26,412
(Decrease) increase in accounts payable (244,646) 66,355
(Decrease) increase in other current liabilities 260,080 (132,176)
Operating lease liabilities (26,412)
Net cash used in operating activities 821,023 (1,426,868)
Cash flows from investing activities:    
Purchase of property and equipment (6,378) (931)
Net cash used in investing activities (6,378) (931)
Cash flows from financing activities    
Proceeds allocated to Common Stock from Series D offering, net of cash issuance expenses 750,116 924,398
Proceeds allocated to Series D Warrants, net of cash issuance expenses 5,995 773,302
Net cash provided by financing activities 756,111 1,697,700
Effect of exchange rate changes on cash, cash equivalents and restricted cash 6,467 (9,296)
Increase (decrease) in cash, cash equivalents, and restricted cash (64,823) 260,605
Cash, Cash equivalents, and restricted cash at beginning of the period 149,684 53,782
cash, cash equivalents, and restricted cash at end of the period $ 84,861 $ 314,387